HYPERTENSION Endothelin-receptor antagonists for treating hypertension

被引：0
|
作者：
Weir, Matthew R. [1 ]
机构：
[1] Univ Maryland, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21201 USA
来源：
NATURE REVIEWS NEPHROLOGY | 2010年 / 6卷 / 04期
关键词：
RESISTANT HYPERTENSION; ASSOCIATION;
D O I：
10.1038/nrneph.2010.14
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Are selective endothelin-receptor antagonists really an important new advance for treating patients with treatment-resistant hypertension? The evidence from a recent study leaves us with some uncertainty.
引用
收藏
页码：192 / 194
页数：4
相关论文
共 50 条
  • [41] Endothelin receptor antagonists: a place in the management of essential hypertension?
    Burnier, Michel
    Forni, Valentina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (03) : 865 - 868
  • [42] The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension
    Krum, H
    Viskoper, RJ
    Lacourciere, Y
    Budde, M
    Charlon, V
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (12): : 784 - 790
  • [43] Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats
    Chen, SJ
    Chen, YF
    Meng, QC
    Durand, J
    Dicarlo, VS
    Oparil, S
    JOURNAL OF APPLIED PHYSIOLOGY, 1995, 79 (06) : 2122 - 2131
  • [44] Endothelin-receptor antagonists: Heart failure drugs of the future?
    Fricker, J
    LANCET, 1996, 348 (9041): : 1573 - 1573
  • [45] Evolution of Patients with Pulmonary Arterial Hypertension Starting Macitentan After the Discontinuation of Other Endothelin-Receptor Antagonists: Results of a Retrospective Study
    Cadenas-Menendez, Sergio
    Alvarez Vega, Pablo
    Oterino Manzanas, Armando
    Alonso Lecue, Pilar
    Roig Figueroa, Vicente
    Bedate Diaz, Pedro
    Ortiz de Saracho, Juan
    Cifrian Martinez, Jose Manuel
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2020, 20 (05) : 481 - 487
  • [46] Endothelin antagonists and pulmonary hypertension
    Simonsen, U.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 18 - 18
  • [47] Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats
    Hill, NS
    Warburton, RR
    Pietras, L
    Klinger, JR
    JOURNAL OF APPLIED PHYSIOLOGY, 1997, 83 (04) : 1209 - 1215
  • [48] Evolution of Patients with Pulmonary Arterial Hypertension Starting Macitentan After the Discontinuation of Other Endothelin-Receptor Antagonists: Results of a Retrospective Study
    Sergio Cadenas-Menéndez
    Pablo Álvarez Vega
    Armando Oterino Manzanas
    Pilar Alonso Lecue
    Vicente Roig Figueroa
    Pedro Bedate Díaz
    Juan Ortiz de Saracho
    José Manuel Cifrián Martínez
    American Journal of Cardiovascular Drugs, 2020, 20 : 481 - 487
  • [49] Treatment of pulmonary arterial hypertension by endothelin receptor antagonists in 2008
    Cacoub, P.
    Amoura, Z.
    Langleben, D.
    REVUE DE MEDECINE INTERNE, 2008, 29 (04): : 283 - 289
  • [50] Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension
    Montani, D.
    Humbert, M.
    REVUE DES MALADIES RESPIRATOIRES, 2010, 27 (02) : 103 - 105
12345